Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syndax Pharma (NQ: SNDX ) 18.98 +0.12 (+0.64%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Syndax Pharma < Previous 1 2 3 4 Next > This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday October 24, 2024 Via Benzinga FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication August 15, 2024 The FDA has approved Incyte and Syndax Pharmaceuticals' Niktimvo for chronic graft-versus-host disease in patients after at least two prior therapies, providing new hope for those with this serious... Via Benzinga Exposures Product Safety Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD) August 14, 2024 From Incyte and Syndax Pharmaceuticals Via Business Wire Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors August 01, 2024 From Sagimet Biosciences Inc. Via GlobeNewswire Syndax Pharmaceuticals: Q4 Earnings Insights February 27, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga 3 Biotech Stocks That Could Make Your Summer Unforgettable July 30, 2024 If you want to do well with biotech stocks, trade the anticipation of news. Here are three stocks to consider. Via InvestorPlace Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END Via FinancialNewsMedia Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger June 10, 2024 From Pyxis Oncology Via GlobeNewswire Earnings Preview: Syndax Pharmaceuticals February 26, 2024 Via Benzinga Earnings Outlook For Syndax Pharmaceuticals November 01, 2023 Via Benzinga Analyst Ratings for Syndax Pharmaceuticals October 17, 2023 Via Benzinga Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 From FN Media Group LLC Via GlobeNewswire Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket May 29, 2024 Via Benzinga SNDX Stock Earnings: Syndax Pharmaceuticals Beats EPS for Q1 2024 May 08, 2024 SNDX stock results show that Syndax Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Is The Stock Market Ready To Plunge? The Warning Signs Are Here... February 21, 2024 Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move. Via Talk Markets What's Going On With Leukemia-Focused Syndax Pharmaceuticals Stock Today? December 11, 2023 Syndax Pharmaceuticals Inc (NASDAQ: SNDX) shares are trading higher after the company shared data from multiple trials of revumenib in combination with standard-of-care agents in patients with... Via Benzinga Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease December 10, 2023 From Incyte and Syndax Pharmaceuticals Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session November 09, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023 October 11, 2023 Via Benzinga What's Going On With Syndax Pharmaceuticals Stock Monday? October 02, 2023 Syndax Pharmaceuticals Inc (NASDAQ: SNDX) announced topline data from the AUGMENT-101 trial of revumenib in adult and pediatric patients with relapsed/refractory (R/R) KMT2A-rearranged (KMT2Ar) acute... Via Benzinga Earnings Scheduled For November 2, 2023 November 02, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. Via Benzinga Stocks That Hit 52-Week Lows On Thursday October 05, 2023 On Thursday, 369 companies hit new 52-week lows. Via Benzinga Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket October 02, 2023 Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session September 29, 2023 Via Benzinga Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 29, 2023 Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. Via Benzinga Stocks That Hit 52-Week Lows On Friday September 29, 2023 Friday's session saw 112 companies set new 52-week lows. Via Benzinga Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday September 29, 2023 U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session. Corcept Therapeutics Incorporated (NASDAQ: CORT) shares... Via Benzinga Topics Stocks Exposures US Equities Stocks That Hit 52-Week Lows On Thursday September 21, 2023 During the session on Thursday, 461 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday September 15, 2023 Friday's session saw 169 companies set new 52-week lows. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
